EX-99.1 2 ardt-q226x8xkxex991.htm EX-99.1 ARDT - Q2 26 - 8-K - EX99.1 1 Exhibit 99.1 Ardent Health Reports Second Quarter 2026 Results Brentwood, Tenn. (August 4, 2026) - Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended June 30, 2026. Second Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue Net Income Attributable to Ardent Health $1.62 billion $17 million Total Revenue Net Income Attributable to Ardent Health $1.62 billion $17 million Total Revenue Net Income Attributable to Ardent Health $1.62 billion $17 million Adjusted EBITDA(1) Adjusted EBITDAR(1) $115 million $157 million Adjusted…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
Ardent Health, Inc.
ARDTNYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 4, 2026, Ardent Health, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.…
Company context
Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. The Company delivers care through its subsidiaries, which include 30 acute care hospitals and more than 280 sites of care with over 1,800 employed and affiliated providers across six states. Anchored by a shared operating model and a commitment to
Current securities
Recent company filings
- Other EventsSep 4, 2026
- 10-Q filingAug 10, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJun 30, 2026
- 4 filingJun 8, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureJun 2, 2026